3September: Pleased as punch to announce I'll be delivering my now-annual "Top 10 U.S. Biopharma Clusters" presentation at the BioHealth Capital Region (BioHealth Cap Region)'s upcoming 2024 Forum set for September 17-18 in Rockville, MD. Look forward to meeting everyone at the event!

There has long been an obsession with the ability to take a pill for any ailment or illness, and Biora Therapeutics wants to be able to do that. But can they? Check out my latest story for Inside Precision Medicine insideprecisionmedicine.com/topics/precisi…

Women with Liver Cancer Less Likely to Receive Transplant than Men Women with hepatocellular carcinoma are less likely to receive liver transplants than men particularly if they are shorter in height. Learn more: hubs.li/Q02NJrPm0

To guide individualized treatment for Parkinson’s, Rune Labs launched StrivePD-AI, which can take all of the data collected from StrivePD and write clinical reports to aid patients, caregivers, and clinicians in improving outcomes through optimized care. hubs.li/Q02NP91N0

Mpox Protection: Moderna's New mRNA Vaccine May Beat Today's MVA Shot Investigational #mpox #mRNA vaccine, developed by Moderna, reduces disease severity in primates compared to available vaccines. Learn more: hubs.li/Q02NP91T0

ChatGPT-Like Platform for Digital Pathology Shows Promise in Cancer Diagnostics The researchers' ambition was to create a nimble, versatile ChatGPT-like AI platform that can perform a broad range of cancer evaluation tasks. Read more :hubs.ly/Q02NPvfs0

Regular mobile phone use is linked to increased cardiovascular disease risk, especially among current smokers and people with diabetes. Learn more: hubs.li/Q02NQzRM0

New Prostate Cancer Treatment Shows Promise in Preclinical Studies Researchers tested whether the CDK9 inhibitor CDKI-73 has the potential to overcome castration-resistant prostate cancer (CRPC) treatment resistance. Learn more: hubs.li/Q02NQlF30

A novel blood test to detect levels of potassium isotopes in the blood could be an effective biomarker for the early detection of Alzheimer's disease. Learn more: hubs.li/Q02NQsqQ0

A $2.1 million grant will allow Children’s Hospital Los Angeles and Voxel Healthcare to advance AI-driven clinical decision support product for pediatric brain radiation therapy planning. Read more: hubs.li/Q02NQyLR0

NEW WEBINAR! On 9/12, Dr. Chunping Xu, Senior Director of Chemistry R&D at TriLink BioTechnologies, will provide an overview of mRNA applications in vaccine and therapeutic development. REGISTER: hubs.li/Q02NJVGG0 TriLink BioTech #mRNA

Widespread, opportunistic testing for prostate specific antigen (PSA) could be contributing the overdiagnosis of prostate cancer across Europe, researchers warn. Learn why: hubs.li/Q02NQyzk0

Bayer and NextRNA Therapeutics will jointly develop two first-in-class small molecule programs targeting long non-coding RNA. The deal is worth $500M+. Read more: hubs.li/Q02NQtjj0

Nano Delivery of Drug Combo Shrinks Pancreatic Cancer Tumors in Mice Immunotherapy-based approach to pancreatic cancer treatment combines the delivery of STING and TLR4 innate immune agonists using lipid-based nanoparticles. Read more: hubs.li/Q02NQyLY0

NEW WEBINAR! On 9/19, Dr. Gary Pestano will describe current applications of blood-based Droplet Digital™PCR (ddPCR™) testing in the clinic. Register now to join us for this free webinar sponsored by Bio-Rad Laboratories: hubs.li/Q02NSJDb0 Bio-Rad Life Science

Scientists have uncovered a new cell type in the human brain. They also found non-tumor cells that are neuron-glia hybrids, suggesting that this cell population may contribute to healthy brain function. Read more: hubs.li/Q02NTNX30

Study Sheds Light on How Aging Immune System Drives Cancer Development The research details how the aging immune system contributes to tumor growth and offers potential new avenues for cancer prevention. Read more: hubs.li/Q02NZjf80

Spinal Cord Injury Recovery in Mice Boosted by Immunotherapy Mouse study shows engineered immune cell therapy protects damaged neurons. Learn more: hubs.li/Q02NZjZV0

Xenotransplantation pioneer eGenesis has closed a $191 million financing that will go toward advancing the company's lead candidate, EGEN-2784, a first-in-human study for kidney transplant. Learn more: hubs.li/Q02NZBy00

Gastrointestinal Chemotherapy Tweak Can Reduce Side Effects Omitting the bolus, quick-delivery component of 5-fluorouracil in multi-drug chemotherapy regimens for advanced gastrointestinal cancers can reduce treatment toxicity. Learn more: hubs.li/Q02N-6-y0